These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 18973842)

  • 1. Liver biopsy.
    Bedossa P
    Gastroenterol Clin Biol; 2008 Sep; 32(6 Suppl 1):4-7. PubMed ID: 18973842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of fibrosis in chronic liver diseases.
    Zhou K; Lu LG
    J Dig Dis; 2009 Feb; 10(1):7-14. PubMed ID: 19236541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of hepatitis C: non-invasive fibrosis markers and/or liver biopsy.
    Bedossa P
    Liver Int; 2009 Jan; 29 Suppl 1():19-22. PubMed ID: 19207962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of liver biopsy in the assessment of hepatic fibrosis--its utility and limitations].
    Jin SY
    Korean J Hepatol; 2007 Jun; 13(2):138-45. PubMed ID: 17585187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Assessment of hepatic injury in patients with chronic viral hepatitis].
    Hrstić I; Ostojić R; Vucelić B
    Acta Med Croatica; 2009 Dec; 63(5):371-5. PubMed ID: 20198894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver fibrosis: from the bench to clinical targets.
    Pinzani M; Rombouts K
    Dig Liver Dis; 2004 Apr; 36(4):231-42. PubMed ID: 15115333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive biochemical markers of liver fibrosis.
    Grigorescu M
    J Gastrointestin Liver Dis; 2006 Jun; 15(2):149-59. PubMed ID: 16802010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of liver fibrosis.
    Di Sario A; Feliciangeli G; Bendia E; Benedetti A
    Eur Rev Med Pharmacol Sci; 2004; 8(1):11-8. PubMed ID: 15209150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New diagnostic method for liver fibrosis and cirrhosis.
    Han KH; Yoon KT
    Intervirology; 2008; 51 Suppl 1():11-6. PubMed ID: 18544943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing liver fibrosis.
    Castera L
    Expert Rev Gastroenterol Hepatol; 2008 Aug; 2(4):541-52. PubMed ID: 19072402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sampling variability of liver fibrosis in chronic hepatitis C.
    Bedossa P; Dargère D; Paradis V
    Hepatology; 2003 Dec; 38(6):1449-57. PubMed ID: 14647056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies.
    Bourliere M; Penaranda G; Renou C; Botta-Fridlund D; Tran A; Portal I; Lecomte L; Castellani P; Rosenthal-Allieri MA; Gerolami R; Ouzan D; Deydier R; Degott C; Halfon P
    J Viral Hepat; 2006 Oct; 13(10):659-70. PubMed ID: 16970597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The combination of a blood test and Fibroscan improves the non-invasive diagnosis of liver fibrosis.
    Boursier J; Vergniol J; Sawadogo A; Dakka T; Michalak S; Gallois Y; Le Tallec V; Oberti F; Fouchard-Hubert I; Dib N; Rousselet MC; Konaté A; Amrani N; de Ledinghen V; Calès P
    Liver Int; 2009 Nov; 29(10):1507-15. PubMed ID: 19725892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic accuracy of a fibrosis serum panel (FIBROSpect II) compared with Knodell and Ishak liver biopsy scores in chronic hepatitis C patients.
    Christensen C; Bruden D; Livingston S; Deubner H; Homan C; Smith K; Oh E; Gretch D; Williams J; McMahon B
    J Viral Hepat; 2006 Oct; 13(10):652-8. PubMed ID: 16970596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of FIBROSpect II with histologic and morphometric evaluation of liver fibrosis in chronic hepatitis C.
    Patel K; Nelson DR; Rockey DC; Afdhal NH; Smith KM; Oh E; Hettinger K; Vallée M; Dev A; Smith-Riggs M; McHutchison JG
    Clin Gastroenterol Hepatol; 2008 Feb; 6(2):242-7. PubMed ID: 18187364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of fibrosis markers for staging liver fibrosis in patients with precirrhotic alcoholic liver disease.
    Lieber CS; Weiss DG; Paronetto F;
    Alcohol Clin Exp Res; 2008 Jun; 32(6):1031-9. PubMed ID: 18422837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-invasive assessment of chronic liver and gastric diseases.
    Plebani M; Basso D
    Clin Chim Acta; 2007 May; 381(1):39-49. PubMed ID: 17374528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Histological characteristics of chronic hepatitis C in biopsy material].
    Jármay K; Karácsony G; Ozsvár Z; Nagy I; Schaff Z; Lonovics J
    Orv Hetil; 1998 Aug; 139(33):1955-60. PubMed ID: 9734212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hepatic fibrosis: physiopathology and biological diagnosis].
    Housset C; Guéchot J
    Pathol Biol (Paris); 1999 Nov; 47(9):886-94. PubMed ID: 10609268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of non-invasive markers for predicting liver cirrhosis in patients with chronic hepatitis B.
    Lee KG; Seo YS; An H; Um SH; Jung ES; Keum B; Yim HJ; Jeen YT; Chun HJ; Kim CD; Ryu HS
    J Gastroenterol Hepatol; 2010 Jan; 25(1):94-100. PubMed ID: 19793171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.